Lukas Smolej, MD, PhD, Faculty of Medicine and University Hospital, Charles University, Hradec Králové, Czech Republic, highlights genomic tests available to patients with chronic lymphocytic leukemia (CLL) at a tertiary hospital, including tests for IgHV and TP53 mutational status. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.